Molecular recognition is central to biosensing. Since the first biosensor was developed by
Updike and Hicks (1967) many biosensors have been studied and developed. As shown in …

The spread of viral diseases has caused global concern in recent years. Detecting viral
infections has become challenging in medical research due to their high infectivity and …

Protein misfolding and aggregation are linked to several degenerative diseases and are
responsible for the formation of bacterial inclusion bodies. Roles of molecular chaperones in …

Many industries are striving for the development of more reliable and robust β-galactosidase
biosensors that exhibit high response rate, increased detection limit and enriched useful …

Many recombinant proteins partially aggregate into inclusion bodies during production in
Escherichia coli in batch culture on defined medium. Production on complex medium …

Detection of antibodies is essential for the diagnosis of many diseases including infections,
allergies, and autoimmune diseases. Current heterogeneous immunoassays require …

Cancer is a highly fatal disease, and due to contemporary lifestyle and growing,
environmental pollution chances of cancer are increasing, which is a global threat. The high …

The homogeneous immunosensor design described here utilizes the bivalent nature of the
antibody. Antigen peptide is conjugated using flexible linkers with short complementary …

Biosensors for proteins have shown attractive advantages compared to traditional
techniques in clinical laboratory diagnosis. In virtue of modern fabrication modes and …

Enzymes and ribozymes constitute two classes of biological catalysts. The activity of many
natural enzymes is regulated by the binding of ligands that have different structures than …